Skip to main content
Top

Inflammation Research

Issue Special Issue 1/2003

Content (36 Articles)

Meeting report

Meeting Report

G. Sturman

Regular paper

Mast cell-derived vascular endothelial growth factor (VEGF) and microvascular density in diabetic placentae

D. Szukiewicz, A. Szukiewicz, D. Maslinska, G. Szewczyk, M. Watroba

Regular paper

Pyrethroids do not show relevant ex vivo histamine releasing potency in human basophils

B. Horr, H. Borck, M. Jones, A. Lebert, S. Rieger, F. Diel

Regular paper

Diagnostic use of mucosa oxygenation and histamine release experiments in patients with gastrointestinally mediated allergy (GMA)

M. Raithel, M. Weidenhiller, M. Shaban, R. Abel, H. Tuchbreiter, B. Backhaus, N. Donhauser, H. W. Baenkler, E. G. Hahn

Regular paper

Histamine, dithiaden and human polymorphonuclear leukocytes in vitro

R. Nosál, K. Drábiková, V. Jančinová, M. Číž, A. Lojek

Regular paper

The effects of histamine on the lipopolysaccharide-induced metallothionein-I mRNA expression in the mouse spleen

N. Sogawa, C. A. Sogawa, T. Inoue, M. Nakano, N. Oda, T. Yoneyama, Y. Okano, K. Onodera, H. Furuta

Regular paper

Effects of the SOD mimetic, M40403, on prostaglandin production in an in vivo model of ischemia and reperfusion in rat heart

C. Marzocca, A. Vannacci, S. Cuzzocrea, D. Salvemini, P. F. Mannaioni, E. Masini

Regular paper

Effect of protease-activated receptors on guinea-pig ileum contraction in vitro

B. Y. C. Wan, A. Alic, K. H. Peh, E. S. K. Assem, F. L. Pearce

Regular paper

Identification of novel H3 receptor (H3R) antagonists with cognition enhancing properties in rats

G. B. Fox, J. B. Pan, R. Faghih, T. A. Esbenshade, A. Lewis, R. S. Bitner, L. A. Black, Y. L. Bennani, M. W. Decker, A. A. Hancock

Regular paper

Alcoholics show altered histaminergic neurotransmission in several cortical areas – Preliminary report

K. Alakärppä, E. Tupala, T. Mantere, T-. Särkioja, P. Räsänen, J. Tarhanen, J. Tiihonen, L. Tuomisto

Regular paper

In vitro pharmacological properties of two novel non-imidazole H3 receptor (H3R) antagonists

B. B. Yao, D. G. Witte, T. R. Miller, K. M. Krueger, T. L. Carr, C. H. Kang, R. Faghih, Y. L. Bennani, T. A. Esbenshade, A. A. Hancock

Regular paper

H1 antagonists: receptor affinity versus selectivity

M. Gillard, B. Christophe, B. Wels, M. Peck, R. Massingham, P. Chatelain

Regular paper

D-alanine piperazine-amides: novel non-imidazole antagonists of the histamine H3 receptor

R. Faghih, K. Phelan, T. A. Esbenshade, T. R. Miller, C-H. Kang, K. M. Krueger, B. B. Yao, G. B. Fox, Y. L. Bennani, A. A. Hancock

Regular paper

Histamine H1-agonist properties of histaprodifen derivatives on guinea-pig isolated trachea and ileum

B. Christophe, B. Charlier, W. Schunack, P. Chatelain, M. J. Peck, R. Massingham

Regular paper

Mouse embryonic stem cells express histidine decarboxylase and histamine H1 receptors

Z Wiener, S. Tóth, E. Gócza, J. Kobolák, A. Falus

Regular paper

Standardised evaluation of urinary excretion of N-tele-methylhistamine in different periods of age in a healthy population

S. Winterkamp, M. Weidenhiller, V. Wilken, N. Donhauser, H. W. Schultis, F. Buchwald, E. G. Hahn, M. Raithel

Regular paper

Effects of unfractionated and low molecular weight heparins on diamine oxidase release

M. Biebl, J. Klocker, R. Perkmann, H. Mühlthaler, C. Kolbitsch, G. Fraedrich, H. G. Schwelberger

Regular paper

Alterations in plasma amine oxidase activities in a compartment syndrome model

B. Kalmair, J. Klocker, R. Perkmann, M. Biebl, G. Bodner, C. Kolbitsch, G. Fraedrich, H. G. Schwelberger

Regular paper

Analysis of genetic polymorphisms of enzymes involved in histamine metabolism

J. Petersen, A. Drasche, M. Raithel, H. G. Schwelberger

Regular paper

Expression of histidine decarboxylase in human colonic cancer cells and adenomatous polyps

K. Boér, Z. Darvas, M. Baki, I. Kaszás, Z. Pál, A. Falus

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine